Artificial intelligence is becoming an important part of the pharmaceutical industry. Companies are using AI applications for drug discovery, manufacturing, quality operations, pharmacovigilance, data analysis, and other GxP-related activities. These technologies can improve efficiency, but they also introduce new compliance responsibilities.
AI software used within regulated pharmaceutical environments must be appropriately controlled, validated, documented, and monitored. Organizations also need to address data integrity, cybersecurity, human oversight, change management, and vendor risks.
This guide explains the key aspects of AI software compliance audits in pharma for 2026 and how GxP Cellators can help organizations evaluate the compliance of their AI applications.
What Is AI Software Compliance?
AI software compliance refers to ensuring that artificial intelligence applications used in GxP-regulated activities satisfy relevant regulatory and quality requirements.
Important compliance areas include:
- Computerized system validation under requirements such as 21 CFR Part 11 and EU GMP Annex 11
- Data integrity and ALCOA+ principles
- Change control and AI model version management
- User access controls and audit trails
- Documentation and electronic records
- Human oversight and accountability
- AI vendor and supplier qualification
- Risk management and ongoing monitoring
A compliance audit helps determine whether these controls are properly implemented and whether the AI application remains suitable for its intended GxP use.
The AI Software Compliance Audit Process
Phase 1: Audit Planning
The first stage establishes the scope, objectives, and approach of the audit.
Typical activities include:
- Defining the audit scope and objectives
- Identifying AI applications that require assessment
- Determining applicable regulations and standards
- Reviewing existing policies and documentation
- Preparing an audit plan and compliance checklist
Phase 2: Audit Execution
During execution, auditors evaluate the AI application and supporting processes against defined requirements.
Activities may include:
- Conducting an opening meeting
- Reviewing relevant documentation and records
- Interviewing responsible personnel
- Performing system walkthroughs
- Testing controls and reviewing supporting evidence
- Identifying and documenting compliance findings
Phase 3: Audit Reporting
After completing the assessment, findings are evaluated and formally reported.
This stage generally involves:
- Classifying findings according to risk
- Preparing the audit report
- Conducting a closing or close-out meeting
- Agreeing on corrective actions
- Establishing CAPA implementation timelines
Phase 4: Follow-Up
An audit is not complete simply because the report has been issued. Follow-up activities help confirm that identified issues have been effectively addressed.
Follow-up may include:
- Reviewing CAPA plans
- Verifying corrective action implementation
- Evaluating CAPA effectiveness
- Confirming that findings have been adequately resolved
- Formally closing audit observations
Key Areas of AI Software Compliance Audits
| Audit Area | Key Questions |
|---|---|
| AI System Inventory | Have all AI applications been identified, documented, and risk assessed? |
| AI Governance | Is there a defined governance framework for AI use? |
| Training Data | Are training datasets properly controlled, documented, and governed? |
| Model Development | Is the AI model development process documented and appropriately validated? |
| Model Documentation | Are the model architecture, intended use, limitations, and assumptions documented? |
| Human Oversight | Are appropriate processes established for reviewing AI-generated outputs? |
| Data Integrity | Are access controls, audit trails, and data integrity controls effective? |
| Security | Is the AI application protected against relevant cybersecurity and system-specific risks? |
| Regulatory Compliance | Does the application meet applicable requirements such as 21 CFR Part 11 and EU GMP Annex 11? |
| Vendor Management | Have AI software providers and vendors been appropriately qualified and assessed? |
How GxP Cellators Supports AI Software Compliance Audits
GxP Cellators provides specialized AI software compliance audit services for pharmaceutical and GxP-regulated organizations. Its audit approach considers both the regulatory expectations applicable to GxP systems and the specific risks associated with artificial intelligence technologies.
AI Software Compliance Audit Services Include:
- Full-scope AI software compliance audits
- Pre-audit readiness assessments
- AI governance framework assessments
- Training data quality and governance audits
- AI model validation documentation reviews
- Human oversight process assessments
- Data integrity audits for AI applications
- AI security assessments
- Regulatory compliance reviews
- Vendor and supplier audits for AI applications
- Mock AI audits for inspection preparation
- CAPA verification and follow-up audits
These assessments can help organizations identify compliance weaknesses before they become significant regulatory or operational concerns.
Why Choose GxP Cellators for AI Software Compliance Audits?
Organizations working with AI in regulated environments need auditors who understand both GxP compliance and AI technology. GxP Cellators provides an integrated approach to help businesses assess their AI applications against applicable quality and regulatory expectations.
Key benefits include:
- Auditors experienced in GxP requirements and AI technologies
- Coverage of FDA, EMA, Health Canada, MHRA, and WHO expectations
- Risk-based audit approaches tailored to individual AI applications
- Practical and actionable audit reports
- Support for identifying and remediating compliance gaps
- Confidential handling of proprietary systems and information
Frequently Asked Questions
Q1: What is AI software compliance in pharma?
AI software compliance in pharma means ensuring that artificial intelligence applications used in GxP activities meet applicable requirements for validation, data integrity, documentation, human oversight, security, and vendor management.
Q2: Which regulations apply to AI software in pharma?
Depending on the intended use and jurisdiction, relevant requirements may include 21 CFR Part 11 for electronic records and signatures and EU GMP Annex 11 for computerized systems. Data integrity expectations based on ALCOA+ principles are also important. GAMP 5 can provide a risk-based framework for computerized system validation.
Q3: How often should AI software compliance audits be conducted?
Audit frequency should be determined according to the risk associated with the AI application. High-risk AI systems may require more frequent assessments, potentially annually, while lower-risk applications may follow longer audit intervals. Significant system changes, incidents, or regulatory developments can also trigger an audit.
Q4: What are common findings in AI software compliance audits?
Common findings can include incomplete AI system inventories, weak governance frameworks, insufficient training data documentation, inadequate model validation records, weak change control, incomplete data integrity controls, and insufficient human oversight of AI-generated outputs.
Q5: How does GxP Cellators support AI software compliance audits?
GxP Cellators supports organizations through full-scope AI software compliance audits, pre-audit readiness assessments, AI governance reviews, training data assessments, model validation documentation reviews, data integrity assessments, vendor audits, and mock inspection activities.
Q6: How do I contact GxP Cellators for AI software compliance audit support?
Organizations seeking support with AI software compliance audits can contact GxP Cellators to discuss their requirements, AI applications, audit scope, and compliance objectives.
Contact GxP Cellators
If your organization uses AI applications within pharmaceutical or other GxP-regulated activities and requires compliance assessment, GxP Cellators can provide specialized audit support.
Contact GxP Cellators: /contact/
